Item
ASCORBIC ACID USP FN GR KOSHER LUWEI (3020672 215 11M)
Food Ingredient
Attributes
- Gluten-free
- Halal
- Kosher
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Shuangfeng Industrial Park Zichuan District Zibo City, SD 255000 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Allergens.pdf | 2/28/2024 | 2/27/2026 |
| Animal Testing Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Animal Testing Statement.pdf | 4/15/2024 | 4/15/2026 |
| Lot Code | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | batch number statement.pdf | 5/10/2022 | 5/9/2025 |
| BSE - TSE | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | BSE_TSE_.pdf | 5/12/2022 | 5/11/2025 |
| CoA Sample | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | coa-3240113005.pdf | 3/8/2024 | 3/8/2026 |
| Country of Origin | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | COUNTRY OF ORIGIN.pdf | 9/1/2022 | 8/31/2025 |
| Dietary Supplement Questionnaire | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Dietary Supplement Questionnaire.pdf | 7/20/2023 | 7/19/2024 |
| WADA/NSF/NFL Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Doping Free (WADA) Statement.pdf | 7/18/2023 | 7/17/2025 |
| California Prop. 65 | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | e California Proposition 65 Statement.pdf | 4/15/2024 | 4/15/2026 |
| EtO Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | ETO DECLARATION- VC.pdf | 4/15/2024 | 4/15/2026 |
| HACCP Process Flow Diagram | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Flow Chart-VC.pdf | 4/15/2024 | 4/15/2026 |
| FSVP Assessment Form | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | FSVP Assessment Form.pdf | 7/24/2023 | 7/23/2024 |
| Gluten | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Gluten Free Statement.pdf | 4/15/2024 | 4/15/2026 |
| GRAS/NDI/ODI Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | GRAS Compliance Confirmation.pdf | 1/28/2022 | 1/27/2025 |
| HARPC Food Safety Plan (Item) | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | HARPC Food Safety Plan Statements.pdf | 11/2/2023 | 11/1/2026 |
| Heavy Metal | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | heavy metal for VC.pdf | 4/27/2023 | 4/26/2025 |
| Label Claims | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | IMG_20240307_152846.jpg | 4/15/2024 | 4/15/2026 |
| Label Sample | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | IMG_20240307_152846.jpg | 4/15/2024 | 4/15/2025 |
| Label Guidance | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | IMG_20240307_152846.jpg | 4/15/2024 | 4/15/2026 |
| No Animal Ingredient Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Ingredient Statement.pdf | 7/17/2023 | 7/16/2024 |
| Ingredient Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Ingredient Statement.pdf | 2/16/2024 | 2/15/2025 |
| Irradiation Status Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | irradition.pdf | 2/16/2024 | 2/15/2026 |
| Item Questionnaire | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Item Questionnaire.pdf | 1/28/2022 | 1/27/2025 |
| Melamine | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Melamine Declaration.pdf | 7/17/2023 | 7/16/2024 |
| Halal | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | MUI-HALAL certificate 2022.pdf | 11/30/2022 | 11/29/2026 |
| National Bioengineered Food Disclosure Standard (Simplified) | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | National Bioengineered Food Disclosure Standard (Simplified).pdf | 1/28/2022 | 1/27/2025 |
| Natural | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Natural.Synthetic Statement Template.pdf | 7/17/2023 | 7/16/2024 |
| GMO | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Non-GMO project certificate-2024.pdf | 12/23/2022 | 12/22/2024 |
| Nutrition | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Nutrition.pdf | 3/13/2023 | 3/12/2026 |
| Organic | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Organic use status statement for VC(From Luwei).pdf | 5/14/2023 | 5/14/2026 |
| Kosher | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | OUV2-3B60CA6.pdf | 3/31/2024 | 3/31/2025 |
| Food Contact Packaging Certificate of Compliance | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | PACKING DECLARATION.pdf | 4/12/2023 | 4/11/2025 |
| Pesticide | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Pesticides.pdf | 6/21/2023 | 6/20/2025 |
| Phthalate Esters Letter | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Phthalate Esters.pdf | 7/17/2023 | 7/16/2024 |
| HACCP | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | plan of HACCP.pdf | 1/28/2022 | 1/27/2025 |
| Residual Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Residual Solvents Confirmation.pdf | 7/17/2023 | 7/16/2024 |
| Safety Data Sheet (SDS) | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | SDS.pdf | 7/12/2023 | 7/11/2026 |
| Sewage Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Sewage Statement.pdf | 4/15/2024 | 4/15/2026 |
| Shelf Life | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Shelf Life Statement.pdf | 1/28/2022 | 1/27/2025 |
| Product Specification Sheet | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | SPECIFICATION(revsied).pdf | 8/3/2022 | 8/2/2025 |
| Suitability Requirements | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | Suitability Requirements.pdf | 4/11/2023 | 4/10/2026 |
| Vegan/Vegetarian Statement | Shandong Luwei Pharmaceutical Co., Ltd - Mitsubishi | VEGAN CERTIFICATE.pdf | 3/29/2023 | 3/28/2025 |
